Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Assets: 2020-2023

Historic Assets for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $50.1 million.

  • Candel Therapeutics' Assets fell 41.11% to $50.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $50.1 million, marking a year-over-year decrease of 41.11%. This contributed to the annual value of $77.7 million for FY2022, which is 12.91% down from last year.
  • Candel Therapeutics' Assets amounted to $50.1 million in Q3 2023, which was down 14.73% from $58.7 million recorded in Q2 2023.
  • Over the past 5 years, Candel Therapeutics' Assets peaked at $101.6 million during Q1 2022, and registered a low of $30.7 million during Q2 2021.
  • For the 3-year period, Candel Therapeutics' Assets averaged around $74.9 million, with its median value being $81.3 million (2022).
  • Per our database at Business Quant, Candel Therapeutics' Assets surged by 203.48% in 2022 and then crashed by 41.11% in 2023.
  • Candel Therapeutics' Assets (Quarterly) stood at $38.3 million in 2020, then surged by 133.02% to $89.2 million in 2021, then dropped by 12.91% to $77.7 million in 2022, then slumped by 41.11% to $50.1 million in 2023.
  • Its last three reported values are $50.1 million in Q3 2023, $58.7 million for Q2 2023, and $67.2 million during Q1 2023.